|Description||(R)-(+)-HA-966 is a cell-permeable antagonist/partial agonist at the glycine site of the NMDA receptor.|
|Brife Description||NMDA receptor antagonist|
|Purity||≥98% by HPLC|
|Related CAS||111821-58-0 (S-enantiomer)|
Ro 04-5595 hydrochloride is a selective NMDA receptor inhibitor (Ki = 31 nM).
Orphenadrine Citrate is a skeletal muscle relaxant, it acts in the central nervous system to produce its muscle relaxant effects.
TCN 213 is an NMDA receptor antagonist with selectivity for NR1/NR2A (pIC50 = 5.4) over NR1/NR2B.
Cgp 39653 is a competitive N-Methyl-D-aspartate (NMDA) receptor antagonist. CGP 39653 can selectively bins to the NMDA receptor as an antagonist with high affin...
(-)-MK 801 Maleate
MK-801 is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes.
Conantokin-R is a potent and non-competitive NMDA receptor antagonist with IC50 value of 93 nM. It also has NR2 subunit selectivity. It inhibits inward currents...
L-689,560 is a potent antagonist at the glycine-NMDA receptor site. It is a bioactive chemical.
Felbamate (Felbatol) is an anticonvulsant drug used in the treatment of epilepsy.